Affordable Access

Publisher Website

17 alpha-hydroxyprogesterone caproate vehicle, castor oil, enhances the contractile effect of oxytocin in human myometrium in pregnancy

Authors
Journal
American Journal of Obstetrics and Gynecology
0002-9378
Publisher
Elsevier
Publication Date
Volume
202
Issue
5
Identifiers
DOI: 10.1016/j.ajog.2010.03.023
Keywords
  • Myometrium
  • Preterm
  • Progesterone
Disciplines
  • Biology

Abstract

Objective The possibility exists that the vehicle for 17-alpha-hydroxyprogesterone caproate, castor oil, exerts an effect on human uterine contractility. The aim of this study was to evaluate its effects on contractility of myometrial preparations that were obtained during pregnancy. Study Design Myometrial strips were suspended under isometric conditions. Contractility was induced with oxytocin. Strips were incubated in castor oil or physiologic salt solution and suspended for a further oxytocin challenge. Contractile integrals were compared between both groups. Results Strips that were exposed to castor oil demonstrated increased contractile activity that was elicited by oxytocin (mean contractility value, 165.53% ± 17.03%; n = 8; P = .004), compared with control strips (mean contractility value, 72.57% ± 7.48%; n = 8; P = .003). There was a significant increase in contractile activity of the castor oil–exposed strips, compared with those that were exposed to physiologic salt solution (n = 8; P < .001). Conclusion Exposure of human myometrial preparations to castor oil results in enhanced oxytocin-induced contractility.

There are no comments yet on this publication. Be the first to share your thoughts.